& Conlon, J
no video visit unless clinically necessary Initial review typically completed within 2448 hours after intake Treatments Offered Weekly GLP-1 injections: Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide, and compounded liraglutide Daily (once or twice) oral weight-loss medications: bupropion, metformin, topiramate, B12, naltrexone App-based sleep, nutrition, and exercise guidance: included Additional services : birth control, ED treatment, skincare, mental health Bottom Line Hims and Hers is a solid option for adults who want GLP-1 access through a trusted, gender-specific telehealth brand
Separately, Foundayo (orforglipron) recently became the first non-peptide oral GLP-1 receptor agonist approved by the FDA
Healthcare providers will determine the appropriate dosage and provide instructions on how to self-administer the injection
We tossed around the idea of loans, saving money, changing jobs for better insurance